Totally agree with your comments regarding outlining CUV’s plans. Though I suspect PW, perhaps through force of habit, is still treading a fine line between strategic secrecy and satiating investor demand for info. DNA repair was by any measure the most compelling strategic advance to come out of Clinuvel, one that affects almost the entire planet! There’s not much to be coy about from here on in, you either advance or let you competitors catch up. However, I feel Time is Clinuvel’s greatest enemy now, not other competitors...
Totally agree with your comments regarding outlining CUV’s...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.55 |
Change
-0.030(0.21%) |
Mkt cap ! $730.1M | |||
| Open | High | Low | Value | Volume |
| $14.61 | $14.99 | $14.40 | $446.0K | 30.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 167 | $14.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.57 | 21 | 4 |
View Market Depth
| Last trade - 10.27am 10/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |